Alfasigma to Acquire Intercept Pharmaceuticals for $19.00 per Share in Cash, Expanding the Global Footprint of Alfasigma Via a Leader in Rare and Serious Liver Diseases - Intercept Pharmaceuticals, Inc. ir.interceptpharma.com Submitted by interceptpharmacom4903 on September 26, 2023 at 12:03 PM in business No comments 1